Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novel Heart Failure Drug From Novartis Gains 'Breakthrough Therapy' Designation From FDA
Novel Heart Failure Drug From Novartis Gains 'Breakthrough Therapy' Designation From FDA
Novel Heart Failure Drug From Novartis Gains 'Breakthrough Therapy' Designation From FDA
Submitted by
admin
on June 27, 2013 - 8:52pm
Source:
Forbes
News Tags:
breakthrough therapies
heart failure
Novatis
serelaxin
Headline:
Novel Heart Failure Drug From Novartis Gains 'Breakthrough Therapy' Designation From FDA
Do Not Allow Advertisers to Use My Personal information
